Media coverage about Varian Medical Systems (NYSE:VAR) has been trending somewhat positive recently, Accern reports. The research group identifies negative and positive news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Varian Medical Systems earned a news sentiment score of 0.12 on Accern’s scale. Accern also assigned press coverage about the medical equipment provider an impact score of 45.8777278529056 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

These are some of the news stories that may have impacted Accern Sentiment’s analysis:

Shares of Varian Medical Systems (VAR) traded up $1.33 during mid-day trading on Friday, hitting $109.22. The stock had a trading volume of 667,700 shares, compared to its average volume of 874,494. Varian Medical Systems has a twelve month low of $76.94 and a twelve month high of $109.71. The company has a quick ratio of 1.13, a current ratio of 1.41 and a debt-to-equity ratio of 0.18. The stock has a market capitalization of $9,950.00, a P/E ratio of 28.62, a price-to-earnings-growth ratio of 3.17 and a beta of 0.65.

Varian Medical Systems (NYSE:VAR) last released its quarterly earnings data on Wednesday, October 25th. The medical equipment provider reported $1.09 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.10). The firm had revenue of $739.00 million for the quarter, compared to analyst estimates of $741.69 million. Varian Medical Systems had a net margin of 8.85% and a return on equity of 23.68%. Varian Medical Systems’s revenue for the quarter was down 1.1% on a year-over-year basis. During the same period in the previous year, the business posted $1.03 EPS. analysts anticipate that Varian Medical Systems will post 4.26 EPS for the current fiscal year.

VAR has been the topic of several recent research reports. Zacks Investment Research downgraded Varian Medical Systems from a “hold” rating to a “sell” rating in a report on Friday, October 27th. Citigroup Inc. lifted their target price on Varian Medical Systems from $119.00 to $121.00 and gave the company a “neutral” rating in a research note on Monday, October 30th. BidaskClub downgraded Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $100.00 target price on shares of Varian Medical Systems in a research note on Friday, September 1st. Finally, BTIG Research reiterated a “hold” rating on shares of Varian Medical Systems in a research report on Sunday, October 29th. Three analysts have rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $97.83.

TRADEMARK VIOLATION NOTICE: This news story was originally reported by Watch List News and is owned by of Watch List News. If you are reading this news story on another website, it was stolen and reposted in violation of international copyright laws. The correct version of this news story can be read at https://www.watchlistnews.com/varian-medical-systems-var-earning-somewhat-favorable-press-coverage-report-finds/1709715.html.

In other news, insider Dow R. Wilson sold 15,059 shares of Varian Medical Systems stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $105.41, for a total value of $1,587,369.19. Following the transaction, the insider now directly owns 81,835 shares in the company, valued at $8,626,227.35. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Kolleen T. Kennedy sold 2,021 shares of Varian Medical Systems stock in a transaction dated Monday, November 13th. The stock was sold at an average price of $107.36, for a total value of $216,974.56. Following the completion of the transaction, the executive vice president now owns 27,595 shares in the company, valued at $2,962,599.20. The disclosure for this sale can be found here. In the last three months, insiders have sold 42,761 shares of company stock valued at $4,447,864. Insiders own 0.91% of the company’s stock.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.